© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Researchers have identified biomarkers that can identify NAFLD and rule out advanced fibrosis.
Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.
Large European study finds that more than 1 in 10 people with HIV acquire HCV again.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
An NIH-sponsored peer-recruitment study is part of a larger push to figure out how to drive up the viral suppression rate in the U.S.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
